Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and preclinical advances in PSMA-Directed Antibody-Drug conjugates (ADCs): Current status and hope for the future.
Mirzaei Y, Hussein Mer A, Fattah Maran B, Omidvar L, Misamogooe F, Amirkhani Z, Javaheri Haghighi N, Bagheri N, Keshtkaran Z, Rezaei B, Bargrizaneh F, Jahandideh S, Barpour N, Shahsavarani H, Bazyari A, Abdollahpour-Alitappeh M. Mirzaei Y, et al. Among authors: barpour n. Bioorg Chem. 2024 Dec;153:107803. doi: 10.1016/j.bioorg.2024.107803. Epub 2024 Sep 6. Bioorg Chem. 2024. PMID: 39270526 Review.
Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence.
Khosravanian MJ, Mirzaei Y, Mer AH, Keyhani-Khankahdani M, Abdinia FS, Misamogooe F, Amirkhani Z, Bagheri N, Meyfour A, Jahandideh S, Barpour N, Nikmanesh Y, Shahsavarani H, Abdollahpour-Alitappeh M. Khosravanian MJ, et al. Among authors: barpour n. Life Sci. 2024 Sep 1;352:122910. doi: 10.1016/j.lfs.2024.122910. Epub 2024 Jul 11. Life Sci. 2024. PMID: 39002610 Review.
Progress of antibody-drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies.
Mer AH, Mirzaei Y, Misamogooe F, Bagheri N, Bazyari A, Keshtkaran Z, Meyfour A, Shahedi A, Amirkhani Z, Jafari A, Barpour N, Jahandideh S, Rezaei B, Nikmanesh Y, Abdollahpour-Alitappeh M. Mer AH, et al. Among authors: barpour n. Drug Deliv Transl Res. 2024 Nov;14(11):2963-2988. doi: 10.1007/s13346-024-01564-3. Epub 2024 Apr 10. Drug Deliv Transl Res. 2024. PMID: 38597995 Review.
Corrigendum to "STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance" [Int. Immunopharmacol. 119 (2023) 110160].
Gharibi T, Barpour N, Hosseini A, Mohammadzadeh A, Marofi F, Ebrahimi-Kalan A, Nejati-Koshki K, Abdollahpour-Alitappeh M, Safaei S, Baghbani E, Baradaran B. Gharibi T, et al. Among authors: barpour n. Int Immunopharmacol. 2023 Jun;119:110303. doi: 10.1016/j.intimp.2023.110303. Epub 2023 May 11. Int Immunopharmacol. 2023. PMID: 37179201 No abstract available.
STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balance.
Gharibi T, Barpour N, Hosseini A, Mohammadzadeh A, Marofi F, Ebrahimi-Kalan A, Nejati-Koshki K, Abdollahpour-Alitappeh M, Safaei S, Baghbani E, Baradaran B. Gharibi T, et al. Among authors: barpour n. Int Immunopharmacol. 2023 Jun;119:110160. doi: 10.1016/j.intimp.2023.110160. Epub 2023 Apr 18. Int Immunopharmacol. 2023. PMID: 37080068